Meme Kanseri Tanısı İçin Özniteliklerin Öneminin Değerlendirilmesi Üzerine Bir Çalışma

En yaygın kanser türlerinden biri olan meme kanseri kadınları etkileyen ölümcül bir hastalıktır. Önerilen çalışmada, Wisconsin meme kanseri veriseti üzerinde öznitelik seçimine dayalı Özyinelemeli Özellik Seçimi metodu kullanılarak özniteliklerin önemliliği araştırılmış ve sonrasında Rastele Orman ve Lojistik Regresyon sınıflandırıcı algoritmaları kullanılarak makine öğrenmeleri gerçekleştirilmiştir. Eğitim ve test aşamalarını içeren öğrenme süreci 5 katlı çapraz doğrulama tekniği kullanılarak gerçekleştirilmiştir. Deneysel çalışmalar, Rastgele Orman algoritması kullanılarak en iyi sınıflandırma başarısı ( %98 doğruluk) elde edildiğini göstermiştir

A Study on Assessing the Importance of Attributes for Breast Cancer Diagnosis

Breast cancer, one of the most common types of cancer, is a deadly disease affecting women. The importance of attributes was investigated by using the Recursive Feature Selection based on feature selection on Wisconsin breast cancer dataset, and then the machine learnings were performed by utilizing Random Forest and Logistic Regression classifier algorithms in the proposed study. The learning process involving training and testing phases was performed by utilizing the 5-fold cross-validation technique. Experimental studies showed that the best classification performance (98% accuracy) was achieved by applying the Random Forest algorithm

PDF

___

Breast cancer basics, URL: http://www.webmd.com/breast-cancer/guide/understanding-breast-cancer-basics, (Erişim zamanı; Temmuz, 20, 2017).
A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, “Global cancer statistics”, CA Cancer J. Clin. 61(2), 69–90, 2011.
E.I. Papageorgiou, J. Subramanian, A. Karmegam, N. Papandrianos, “A risk management model for familial breastcancer: A new application using Fuzzy CognitiveMap method”, Computer Methods and Programs in Biomedicine, 122(2), 123–135, 2015
I. Guyon, J. Weston, S. Barnhill and V. Vapnik, “Gene selection for cancer classification using support vector machines”, Mach Learn 46(1-3), 389-422, 2002.
D.W. Hosmer, and S. Lemeshow, “Applied logistic regression, 2nd ed.”, Wiley Series in Probability and Statistics, Canada, 2000.
L. Breiman, “Random forests”, Machine Learn, 45, 5-32, 2001.
Globocan 2012: Estimated Cancer Incidince, Mortaliyty and Prevalence Worldwide 2012, URL: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. (Erişim zamanı; 20 June 2017).
M. Powell, F. Jamshidian, K. Cheyne, J. Nititham, L.A. Prebil, R. Ereman, “Assessing Breast Cancer Risk Models in Marin County, a Population With High Rates of Delayed Childbirth”, Clinical Breast Cancer, 14(3), 212-220, 2014.
Breast Cancer Risk Assessment Tool for Health Care Providers. Office of Cancer Communication. Bethesda (MD): National Cancer Institute; 1998
N. Elsayegh, A.M. Gutierrez Barrera, K.I. Muse, H. Lin, H.M. Kuerer, M. Helm, J.K. Litton, and B.K. Arun, “Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic Testing”, Front Genet, 7, 1-7, 2016.
The International Breast Cancer Intervention Study, URL: https://www.ibis-trials.org/thetrials/ibistrials/ibis-1, (Erişim zamanı; Nisan, 8, 2018).
A. AlDiab, S. Qureshi, K. Al Saleh, F.H. AlQahtani, A. Aleem, A. AlSaif, V. Qureshi, M.R. Qureshi, “Studies on the methods of diagnosis and biomarkers used in early detection of breast cancer in the Kingdom of Saudi Arabia”, World Journal of Medical Sciences, 8(1), 36-47, 2013.
A. Alharbi, F. Tchier, “Using a genetic-fuzzy algorithm as a computer aided diagnosis tool on Saudi Arabian breast cancer database”, Mathematical Biosciences, 286, 39-48, 2017.
E.C. Porto-Mascarenhas, D.X. Assad, H. Chardin, D. Gozal, G.D. Luca Canto, A.C. Acevedo, E.N.S. Guerra, “Salivary biomarkers in the diagnosis of breast cancer: A review”, Critical Reviews in Oncology/Hematology 110, 62–73, 2017.
M. Ramalho, F. Fontes, L. Ruano, S. Pereira, N. Lunet, “Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study”, Breast, 32, 173-178, 2017.
M.L. Peters, J.E. Garber, N. Tung, “Managing hereditary breast cancer risk in women with and without ovarian cancer”, Gynecologic Oncology, 146(1), 205–214, 2017.
S. Pudkasam, K. Tangalakis, N. Chinlumprasert, V. Apostolopoulos, L. Stojanovska, “Breast cancer and exercise: The role of adiposity and immune markers”, Maturitas, 105, 16-22, 2017
A.M. Cimpean, R. Tamma, S. Ruggieri, B. Nico, A. Toma, D. Ribatti, “Mast cells in breast cancer angiogenesis”, Critical Reviews in Oncology/Hematology 115, 23–26, 2017.
B.A. Almutlaq, R.F. Almuazzi, A.A. Almuhayfir, A.M. Alfouzan, B.T. Alshammari, H.S. AlAnzi, H.G. Ahmed, “Breast cancer in Saudi Arabia and its possible risk factors”, Journal of Cancer Policy, 12, 83–89, 2017.
K.E. Lukong, “Understanding breast cancer - The long and winding road”, BBA Clinical, 7, 64–77, 2017.
C. Coleman, “Early Detection and Screening for Breast Cancer, Seminars in Oncology Nursing”, 33(2), 141–155, 2017.
R. Kohavi, “A study of cross-validation and bootstrap for accuracy estimation and model selection”, Proceedings of the 14th international joint conference on Artificial intelligence, 2, 1137-1143, 1995
A. Baratloo, M. Hosseini, A. Negida and G.E. Ashal, “Part 1: Simple Definition and Calculation of Accuracy, Sensitivity and Specificity”, Emerg (Tehran), 3(2), 48-49, 2015.